In chemistry, glycosides are certain molecules in which a sugar part is bound to some other part. Glycosides play numerous important roles in living organisms. Many plants store important chemicals in the form of inactive glycosides; if these chemicals are needed, the glycosides are brought in contact with water and an enzyme, and the sugar part is broken off, making the chemical available for use. Many such plant glycosides are used as medications. In animals (including humans), poisons are often bound to sugar molecules in order to remove them from the body.
Formally, a glycoside is any molecule in which a sugar group is bonded through its anomeric carbon to another group via an O-glycosidic bond or an S-glycosidic bond; glycosides involving the latter are also called thioglycosides. The given definition is the one used by IUPAC. Many authors require in addition that the sugar be bonded to a non-sugar for the molecule to qualify as a glycoside, thus excluding the polysaccharides. The sugar group is then known as the glycone and the non-sugar group as the aglycone or genin part of the glycoside. The glycone can consist of a single sugar group (monosaccharide) or several sugar groups (oligosaccharide).
Molecules containing an N-glycosidic bond are known as glycosylamines and are not discussed in this article. (Many authors in biochemistry call these compounds N-glycosides and group them with the glycosides; this is considered a misnomer and discouraged by IUPAC.)
Much of the chemistry of glycosides is explained in the article on glycosidic bonds. For example, the glycone and aglycone portions can be chemically separated by hydrolysis in the presence of acid. There are also numerous enzymes that can form and break glycosidic bonds. The most important cleavage enzymes are the glycoside hydrolases, and the most important synthetic enzymes in nature are glycosyltransferases. Mutant enzymes termed glycosynthases have been developed that can form glycosidic bonds in excellent yield.
There are a great many ways to chemically synthesize glycosidic bonds. Fischer glycosidation refers to the synthesis of glycosides by the reaction of unprotected monosaccharides with alcohols (usually as solvent) in the presence of a strong acid catalyst. The Koenigs-Knorr reaction is the condensation of glycosyl halides and alcohols in the presence of metal salts such as silver carbonate or mercuric oxide.
We can classify glycosides by the glycone, by the type of glycosidic bond, and by the aglycone.
If the glycone group of a glycoside is glucose, then the molecule is a glucoside; if it is fructose, then the molecule is a fructoside; if it is glucuronic acid, then the molecule is a glucuronide; etc. In the body, toxic substances are often bonded to glucuronic acid to increase their water solubility; the resulting glucuronides are then excreted.
Depending on whether the glycosidic bond lies "above" or "below" the plane of the cyclic sugar molecule, glycosides are classified as α-glycosides or β-glycosides. Some enzymes such as α-amylase can only hydrolize α-linkages; others, such as emulsin, can only affect β-linkages.
Glycosides are also classified according to the chemical nature of the aglycone. For purposes of biochemistry and pharmacology, this is the most useful classification.
Brito-Arias M. Synthesis and Characterization of Glycosides Ed Springer 2007.
US Patent Issued to Phoenix Biotechnology on March 12 for "SCF Extract Containing Cardiac Glycoside" (Texas, California Inventors)
Mar 12, 2013; ALEXANDRIA, Va., March 12 -- United States Patent no. 8,394,434, issued on March 12, was assigned to Phoenix Biotechnology Inc....
US Patent Issued to Phoenix Biotechnology on July 9 for "Method of Treating Neurological Conditions with Cardiac Glycoside" (Maine, Texas Inventors)
Jul 09, 2013; ALEXANDRIA, Va., July 9 -- United States Patent no. 8,481,086, issued on July 9, was assigned to Phoenix Biotechnology Inc. (San...
US Patent Issued to Sirbal on Sept. 24 for "Cardiac Glycoside Analogs in Combination with Emodin for Cancer Therapy" (Israeli Inventor)
Sep 24, 2013; ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 8,541,382, issued on Sept. 24, was assigned to Sirbal Ltd. (Limassol,...
Publication No. WO/2010/068461 Published on June 17, Assigned to Gilead Palo Alto for Ranolazine, Cardiac Glycoside Co-Administration Method (American Inventors)
Jun 18, 2010; GENEVA, June 21 -- Luiz Belardinelli, Kirsten Hoyer and John Shryock, all from the U. S., have developed a method for...